- High gross margin of 92.2%
- Consistently positive technical signals over the last month
- Highly efficient cash conversion (100% FCF/OCF ratio)
Green day on Monday for Fennec Pharmaceuticals, Inc stock after gaining 2.48%
(Updated on Jul 13, 2026)
The Fennec Pharmaceuticals, Inc stock price gained 2.48% on the last trading day (Monday, 13th Jul 2026), rising from $10.49 to $10.75. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.62% from a day low at $10.19 to a day high of $10.87. The price has been going up and down for this period, and there has been a -2.45% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 154 thousand more shares were traded than the day before. In total, 327 thousand shares were bought and sold for approximately $3.52 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 68.05% during the next 3 months and, with a 90% probability hold a price between $16.61 and $19.71 at the end of this 3-month period.
FENC Signals & Forecast
The Fennec Pharmaceuticals, Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.53 and $9.84. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -2.54%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Fennec Pharmaceuticals, Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $9.89 and $9.75. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Fennec Pharmaceuticals, Inc finds support just below today's level at $9.89. If this is broken, then the next support from accumulated volume will be at $9.75 and $9.24.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.675 between high and low, or 6.62%. For the last week, the stock has had daily average volatility of 4.35%.
Our recommended stop-loss: $10.30 (-4.22%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)
Trading Expectations (FENC) For The Upcoming Trading Day Of Tuesday 14th
For the upcoming trading day on Tuesday, 14th we expect Fennec Pharmaceuticals, Inc to open at $10.60, and during the day (based on 14 day Average True Range), to move between $10.50 and $11.00, which gives a possible trading interval of +/-$0.507 (+/-4.83%) up or down from last closing price. If Fennec Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 4.83% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $11.02 (2.51%) than the support at $9.89 (8.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Fennec Pharmaceuticals, Inc stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Fennec Pharmaceuticals, Inc stock to perform well in the short-term.
Current score:
4.032
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 14, 2026 - $10.60 ( 1.38%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
FENC Performance
Trading levels for FENC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 11.28 | 4.90% |
| R2 | 11.02 | 2.50% |
| R1 | 10.86 | 1.02% |
| Price | 10.75 | |
| S1 | 10.34 | -3.78% |
| S2 | 10.18 | -5.26% |
| S3 | 9.93 | -7.66% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 11.03 | 2.60% |
| R1 | 11.02 | 2.51% |
| Price | 10.75 | |
| S1 | 9.89 | -8.00% |
| S2 | 9.75 | -9.30% |
| S3 | 9.24 | -14.05% |
FAQ
Click here for our free guide on how to buy Fennec Pharmaceuticals, Inc Stock.
Buy FENC